Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Biomarkers in Urology, An Issue of Urologic Clinics

Biomarkers in Urology, An Issue of Urologic Clinics

9780323940191
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483.79 zł
411.22 zł Save 72.57 zł Tax included
Lowest price within 30 days before promotion: 411.22 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.
Product Details
Elsevier
94019
9780323940191
9780323940191

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
450
  • Approaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology
    Biomarkers in Urolithiasis
    Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease
    Pathophysiology and Clinical Biomarkers in Interstitial Cystitis
    Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-Muscle-Invasive Bladder Cancer
    Biological Stratification of Invasive and Advanced Urothelial Carcinoma
    The Association Between the Urinary Microbiome and Bladder Cancer
    Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer
    Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
    Targeted Molecular Imaging as a Biomarker in Urologic Oncology
    Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
    The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
    Current and Future Biomarkers in the Management of Renal Cell Carcinoma
Comments (0)